36 results
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing
424B4
rhvvgjw3n71k5l9
11 Oct 22
Prospectus supplement with pricing info
8:27am
8-K
EX-1.1
p6z9syqudi7gw
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
8-K
EX-1.1
464deg rx41j
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm